Stephens Inc Takeda Pharmaceutical CO LTD Transaction History

Stephens Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 07, 2022	SELL	$13.17 - $16.4 $188,554 - $234,798	-14,317 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$16.3 - $17.26 $58,973 - $62,446	3,618 Added 33.82%	14,317 $235,000
Q2 2021 Aug 12, 2021	BUY	$16.55 - $18.64 $177,068 - $199,429	10,699 New	10,699 $180,000
Q4 2020 Feb 10, 2021	SELL	$15.39 - $18.97 $164,288 - $202,504	-10,675 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$17.1 - $19.19 $33,635 - $37,746	-1,967 Reduced 15.56%	10,675 $190,000
Q2 2020 Aug 24, 2020	SELL	$14.59 - $19.5 $5,981 - $7,995	-410 Reduced 3.14%	12,642 $227,000
Q1 2020 May 14, 2020	BUY	$13.02 - $20.31 $28,787 - $44,905	2,211 Added 20.39%	13,052 $198,000
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $14,567 - $17,976	-863 Reduced 7.37%	10,841 $214,000
Q3 2019 Oct 18, 2019	BUY	$16.15 - $17.99 $11,821 - $13,168	732 Added 6.67%	11,704 $201,000
Q2 2019 Aug 01, 2019	BUY	$16.58 - $20.49 $181,915 - $224,816	10,972 New	10,972 $194,000

319

70.3M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.